Blood-brain interfaces and bilirubin-induced neurological diseases

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Specialized cellular barriers, including the blood-brain barrier and choroid plexus epithelium, control molecular exchange between blood and brain.
• These interfaces are vital for neuroprotection, trophic functions, and proper brain development and maturation.
• Bilirubin's role in the brain is influenced by transport and metabolic pathways within these barriers.

Purpose of the Study:

• To review mechanisms regulating bilirubin's cerebral bioavailability at physiological conditions.
• To explore the role of transporters (ABC, OATP) and metabolic enzymes (GSTs) in bilirubin detoxification.
• To identify potential pharmacological targets for preventing bilirubin neurotoxicity and understand barrier alterations in hyperbilirubinemia.

Main Methods:

• Literature review of transport and metabolic pathways involved in bilirubin regulation in the brain.
• Analysis of the role of ABC and OATP transporters, glutathione-S-transferases, and metabolic pathways.
• Examination of regulatory mechanisms and their potential as pharmacological targets.

Main Results:

• Specific transporters and metabolic enzymes are implicated in controlling bilirubin entry and detoxification within brain barriers.
• Regulatory pathways for these mechanisms can be induced, offering potential therapeutic intervention points.
• Alterations in barrier function can contribute to neurological damage in hyperbilirubinemia.

Conclusions:

• Brain barriers play a critical role in managing bilirubin levels, impacting neuroprotection and development.
• Understanding these mechanisms is key to developing strategies against bilirubin-induced neurological dysfunction.
• The blood-brain and blood-cerebrospinal fluid barriers are crucial for drug delivery in treating bilirubin-related brain injury.